Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Maximus vs Trimi Health

An in-depth comparison of two leading GLP-1 Providers

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Maximus logo

Maximus

6.5
★★★☆☆3.3/5

Best for: coverage in all 50 states, which most of the register will not confirm

Visit Maximus
VS
Trimi Health logo

Trimi Health

9.4
★★★★4.7/5

Best for: knowing which pharmacy fills the vial — it names VialsRx

Visit Trimi Health

Two GLP-1 Providers chasing the same patients, trading off price, geography and what lands in the box differently. On our scoring, Trimi Health opens cheaper — $99/mo against $199.99, and Trimi Health finishes ahead, 9.4 to 6.5. What follows: the prices, what each plan actually covers, the six-dimension score, where each one is weak, and who should pick which.

Pricing

Maximus

1-Month plan, flat-rate across all dose tiersCompounded
$249.99/mo
semaglutide

4-Month plan $199/mo; 12-Month plan $150/mo ('BEST VALUE... Save $100'); homepage teaser 'GLP-1 Starting at $149.99'; /weight-loss hub also shows 'Starting at $116 /28-day supply' (teaser, unreconciled with product page)

1-Month plan, flat-rate across all dose tiersCompounded
$359.99/mo
tirzepatide

4-Month plan $299/mo; 12-Month plan $240/mo; product page 'Personalized doses from $198 /mo' and hub 'Starting at $198 /28-day supply'; homepage teaser 'GLP-1 + GIP Starting at $249.99'

Starting atCompounded
$199.99/mo
orforglipron (foundayo)

NEW: brand-name oral GLP-1; 'Foundayo starting at $199.99 /mo'

Starting atCompounded
$249.99/mo
semaglutide (wegovy)

NEW brand-name option

Starting atCompounded
$349.99/mo
semaglutide (ozempic)

NEW brand-name option

Starting atCompounded
$349.99/mo
semaglutide (wegovy)

NEW brand-name option

Starting atCompounded
$449.99/mo
tirzepatide (zepbound)

NEW brand-name option; multi-dose KwikPen at same self-pay price as vial

Starting atCompounded
$1249.99/mo
tirzepatide (mounjaro)

NEW brand-name option; on-label tirzepatide

Trimi Health

All doses (flat)Compounded
$175/mo
semaglutide

Billed monthly. Flat price at every dose.

All doses (flat)Compounded
$145/mo
semaglutide

Quarterly plan: billed $435 every 3 months.

All doses (flat)Compounded
$120/mo
semaglutide

Bi-annual plan: billed $720 every 6 months.

All doses (flat)Compounded
$99/mo
semaglutide

Annual plan: billed $1,188 yearly upfront (or BNPL via Affirm/Klarna/Afterpay). This is the advertised headline price.

All doses (flat)Compounded
$235/mo
tirzepatide

Billed monthly. Flat price at every dose.

All doses (flat)Compounded
$199/mo
tirzepatide

Quarterly plan: billed $597 every 3 months.

All doses (flat)Compounded
$175/mo
tirzepatide

6-month plan: billed $1,050 every 6 months.

All doses (flat)Compounded
$125/mo
tirzepatide

Annual plan: billed $1,500 yearly upfront (or BNPL). This is the advertised headline price.

What’s included

Maximus

Covered by the monthly price

Medication

In the price

Clinician visits

Not stated

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Trimi Health

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Score breakdown

Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.

Maximus

6.5/10

Overall

Trimi Health

9.4/10

Value25%

3.0A
vs
B
10.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

7.5A
vs
B
8.0

Trust & Safety15%

4.5A
vs
B
10.0

Accessibility10%

10.0A
vs
B
10.0

Support10%

4.5A
vs
B
7.0

Features & Coverage

FeatureMaximusTrimi Health
Starting Price$199.99/mo$99/mo
Features5 features3 features
States Available5150
Compounded✓ Yes✓ Yes
Brand Name
FSA/HSA Accepted
FDA Warnings1 warningNone

About Maximus

Maximus is a men's health platform selling compounded semaglutide from $149.99/mo on a 12-month plan, plus compounded tirzepatide, alongside testosterone replacement therapy and longevity treatments. It covers all 50 states plus DC, and a microdose protocol is available for patients with less weight to lose.

Read our full Maximus review →

About Trimi Health

Trimi Health is a telehealth seller whose compounded GLP-1 pricing is among the lowest available.

Read our full Trimi Health review →

Pros & Cons

Maximus

What we like

  • Semaglutide at $249.99 a month, within the normal band around this register's $189 median for the same drug and form
  • Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
  • The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
  • The monthly figure covers medication and shipping
  • Coverage is published for all 50 states
  • A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake

Watch-outs

  • No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
  • 1 FDA warning letter matched to this operator in our enforcement register — read what the letter alleges, since a letter discloses a problem rather than disqualifying a seller
  • Its orforglipron and semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Trimi Health

What we like

  • Semaglutide at $99 a month, 48% below the $189 median for the same drug and form across this register
  • Tirzepatide at $125 a month, 53% below the $267 median for the same drug and form across this register
  • Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
  • The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
  • The monthly figure covers medication, consult, shipping
  • Coverage is published for all 50 states
  • Names 2 dispensing pharmacies, which most sellers in this register do not do
  • No FDA warning letter matched this operator when we searched our enforcement register

Watch-outs

  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Trimi Health

Trimi Health takes it, 9.4 against 6.5, and it is especially strong on knowing which pharmacy fills the vial — it names VialsRx. Maximus is no weak second and may fit you better on coverage in all 50 states, which most of the register will not confirm.

Choose Maximus if…

You want coverage in all 50 states, which most of the register will not confirm and an opening price near $199.99 a month.

Choose Trimi Health if…

You want knowing which pharmacy fills the vial — it names VialsRx and an opening price near $99 a month.

Ready to start? Vetted GLP-1 providers

Vetted telehealth providers that prescribe GLP-1 online.

No insurance needed · vetted by our editors

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

6.5

Direct Meds

Compounded semaglutide at $249/month

7.7

Try Ageless

Semaglutide at $119/month, 37% under the register median

8.8

Found

Tirzepatide at $169/month, 37% under the register median

Maximus vs Trimi Health: FAQ

Glossary

The words sellers use, defined. Tap any term.

Continue exploring Maximus and Trimi Health head-to-heads in the same category.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.